SGLT-2 inhibitors (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SGLT-2 inhibitors (class), covering 2024-09-23 to 2024-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes